Advertisement
Screener

PUMA BIOTECHNOLOGY, INC. (PBYI) Net Margin

PUMA BIOTECHNOLOGY, INC. (PBYI) Net Margin

  • 2026-06-30: Net Margin 14.49%.
  • 2026-03-31: Net Margin -8.37%.
  • 2025-12-31: Net Margin 17.81%.
  • 2025-09-30: Net Margin 16.23%.

Complete source-backed net margin history.

Available history
2017-09-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-3014.49%
2026-03-31-8.37%
2025-12-3117.81%
2025-09-3016.23%
2025-06-3011.17%
2025-03-316.46%
2024-12-3132.68%
2024-09-3025.23%
2024-06-30-9.62%
2024-03-31-11.00%
2023-12-3117.00%
2023-09-3010.33%
2023-06-303.90%
2023-03-312.65%
2022-12-31-8.54%
2022-09-30-0.63%
2022-06-3015.74%
2022-03-31-7.44%
2021-12-317.63%
2021-09-30-96.60%
2021-06-30-9.56%
2021-03-3116.84%
2020-12-31-28.53%
2020-09-30-61.99%
2020-06-304.81%
2020-03-31-33.06%
2019-12-31-17.80%
2019-09-30-29.96%
2019-06-30-69.41%
2019-03-31-10.18%
2018-12-31-43.18%
2018-09-30-22.67%
2018-06-30-87.33%
2018-03-31-36.60%
2017-12-31-296.55%
2017-09-30-1270.03%

Annual Net Margin

DateNet Margin
2025-12-3113.62%
2024-12-3113.14%
2023-12-319.16%
2022-12-310.00%
2021-12-31-11.51%
2020-12-31-26.65%
2019-12-31-27.77%
2018-12-31-45.25%
2017-12-31-1054.56%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ARVINAS, INC. (ARVN)United States$0.510B58.38
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
Evolus, Inc. (EOLS)United States$0.519B-13.32
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76